NeuroStat: Phase I completed

NeuroVive completed a Phase I trial comparing intravenous NeuroStat vs. Sandimmune, an injectable cyclosporine A marketed by Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland). NeuroVive is majori...